Jerald Lim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jerald Lim has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Andrew W. Browne
Gavin Herbert Eye Institute – Center for Translational Vision Research University of California Irvine Irvine California USA
1 shared publication Ash Pirouz
Retina Consultants of Orange County, Fullerton, CA, USA
1 shared publication- Austen Hamilton
Brunson Center for Translational Vision Research, University of California Irvine, Irvine, CA 92697, USA
1 shared publication Austin R. Fox
1 shared publication- Blaze Ann Carbonell
Department of Ophthalmology, University of California, Irvine, CA; and
1 shared publication Cinthia Kim
1 shared publication
Latest Publications
- Open Access
- 4 August 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 292, 263-274
In Vivo Microscopic Assessment of Ocular Surface Changes Induced By Antiglaucoma Medications
- 4 August 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 292, 263-274
Open AccessIn Vivo Microscopic Assessment of Ocular Surface Changes Induced By Antiglaucoma Medications
- Open Access
- 25 March 2026
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
- Vol. 10 (5) , 1077-1080
Evolving Congenital Hypertrophy of the Retinal Pigment Epithelium in a Pediatric Patient
Purpose: To describe the longitudinal evolution of a solitary congenital hypertrophy of the retinal pigment epithelium lesion demonstrating progressive enlargement and increasing border irregularity over time. Methods: A single case was reviewed. Results: A 13-year-old boy presented with an evolving and enlarging congenital hypertrophy of the retinal pigment epithelium lesion over a 7-year period. Fundus images obtained when the patient was 7 years old showed a solitary, circular lesion with a hypopigmented center and mildly irregular, hyperpigmented borders that measured 1.5 mm × 1.5 mm. At age 13, the lesion had increased to 3.1 mm × 3.8 mm. Over the next 1.5 years, it enlarged further to 4.5 mm × 4.3 mm, accompanied by increasing irregularity and scalloping of the lesion borders. Conclusions: Although solitary congenital hypertrophy of the retinal pigment epithelium lesions are generally stable and asymptomatic, this case demonstrates that they may enlarge and become irregular over time. While most lesions remain benign with a good prognosis, regular monitoring is warranted to assess for atypical changes and potential malignant transformation.
- 25 March 2026
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
- Vol. 10 (5) , 1077-1080
Open AccessEvolving Congenital Hypertrophy of the Retinal Pigment Epithelium in a Pediatric Patient
Purpose: To describe the longitudinal evolution of a solitary congenital hypertrophy of the retinal pigment epithelium lesion demonstrating progressive enlargement and increasing border irregularity over time. Methods: A single case was reviewed. Results: A 13-year-old boy presented with an evolving and enlarging congenital hypertrophy of the retinal pigment epithelium lesion over a 7-year period. Fundus images obtained when the patient was 7 years old showed a solitary, circular lesion with a hypopigmented center and mildly irregular, hyperpigmented borders that measured 1.5 mm × 1.5 mm. At age 13, the lesion had increased to 3.1 mm × 3.8 mm. Over the next 1.5 years, it enlarged further to 4.5 mm × 4.3 mm, accompanied by increasing irregularity and scalloping of the lesion borders. Conclusions: Although solitary congenital hypertrophy of the retinal pigment epithelium lesions are generally stable and asymptomatic, this case demonstrates that they may enlarge and become irregular over time. While most lesions remain benign with a good prognosis, regular monitoring is warranted to assess for atypical changes and potential malignant transformation.
- Open Access
- 6 February 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (2) , 188
A Novel, Low-Cost, 3D-Printed Motorized Injector for Retinal Sheet Transplantation
Retinal transplantation offers promise for restoring vision in advanced retinal degeneration. However, manual delivery of retinal sheets is often hindered by imprecise placement and collateral tissue damage resulting from instrument instability. We introduce a novel, 3D-printed, motorized retinal sheet injector designed to enhance placement accuracy and minimize tissue injury. The motorized injector features an Arduino-controlled foot pedal with three discrete actuator positions (“Min”, “Mid”, “Max”). When compared via frame-by-frame motion analysis, the motorized system reduced tip variance by approximately threefold over manual methods. In addition, in in vitro gelatin trials, the motorized injector achieved significantly higher placement accuracy versus the manual injector, which suffered from occasional complete misplacements. The novel motorized retinal sheet injector markedly improves stability and placement accuracy relative to manual methods, potentially reducing complications associated with subretinal delivery. Safer subretinal delivery can pave the way for innovative research and advanced treatment for retinal disease.
- 6 February 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (2) , 188
Open AccessA Novel, Low-Cost, 3D-Printed Motorized Injector for Retinal Sheet Transplantation
Retinal transplantation offers promise for restoring vision in advanced retinal degeneration. However, manual delivery of retinal sheets is often hindered by imprecise placement and collateral tissue damage resulting from instrument instability. We introduce a novel, 3D-printed, motorized retinal sheet injector designed to enhance placement accuracy and minimize tissue injury. The motorized injector features an Arduino-controlled foot pedal with three discrete actuator positions (“Min”, “Mid”, “Max”). When compared via frame-by-frame motion analysis, the motorized system reduced tip variance by approximately threefold over manual methods. In addition, in in vitro gelatin trials, the motorized injector achieved significantly higher placement accuracy versus the manual injector, which suffered from occasional complete misplacements. The novel motorized retinal sheet injector markedly improves stability and placement accuracy relative to manual methods, potentially reducing complications associated with subretinal delivery. Safer subretinal delivery can pave the way for innovative research and advanced treatment for retinal disease.